Dr. Andrew Nerlinger is a physician, venture capital investor, and social impact innovator. He is the Co-founder of PandemicTech, an Austin-based venture philanthropy launched in 2016 that supports health security innovators on the front lines of fighting pandemic infectious disease threats. He is also a Venture Partner at Bill Wood Ventures, an Austin-based family office that invests in early stage technology companies. He is the co-founder and Managing Director of Endura Ventures, an Austin-based management consultancy that advises clients on healthcare investment and philanthropy. Dr. Nerlinger previously was a Partner at Vesalius Ventures, an early stage telemedicine and digital health venture capital firm based in Houston, and served as an international business development consultant for Biodex, a nuclear medicine and physical medicine and rehabilitation device company based in Shirley, New York. He is a graduate of the Yale University School of Medicine (MD, 2006) and the University of Notre Dame (BS, Mathematics and Philosophy, 2002).
Project Profile: #WHOTop30Innovators
Andrew Nerlinger | May 20, 2020
The World Health Organization Africa Innovation Challenge: Praia, Cabo Verde. A major first step in developing a platform to scale locally-driven innovations is to create a pipeline of promising innovations.Read More
Project Profile: The Health Meets Tech Infectious Disease Hackathon
Andrew Nerlinger | Jun 24, 2020
PandemicTech partnered with Nigerian public health consultancy firm EpiAFRIC to organize the Health Meets Tech Nigeria Infectious Disease Hackathon in May 2018 at Ventures Park in AbujaRead More